Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 2,251 across all filing types
Latest filing 2020-09-17 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
2020年半年度报告摘要（修订稿）
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2020 Half-Year Report Summary' (半年度报告摘要) and contains detailed financial data for the first half of 2020, including assets, net profit, revenue, and shareholder information. It also includes management discussion and analysis of operating results and accounting policy changes. The document length is 3137 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. The content matches the characteristics of an Interim / Quarterly Report (IR), which covers a period shorter than a full fiscal year and includes actual financial statements and analysis. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2020
2020-09-17 Chinese
简式权益变动报告书（Orchid）
Major Shareholding Notification Classification · 95% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding of Orchid Asia VI Classic Investment Limited in 江西昌九生物化工股份有限公司 (Jiangxi Changjiu Bio-chemical Co., Ltd.). The content includes information about the shareholding increase, the purpose of the shareholding change, the method of equity change, approvals obtained and pending, and legal compliance statements. It references relevant securities laws and regulatory approvals from the China Securities Regulatory Commission (证监会) and Shanghai Stock Exchange. The document is a formal notification of a change in major shareholding and related disclosures, not a full financial report, audit, or earnings release. It fits the definition of a Major Shareholding Notification (MRQ) as it reports a significant change in share ownership levels crossing thresholds and includes detailed disclosures required by law.
2020-09-17 Chinese
未来三年股东回报规划（2020年-2022年）
Regulatory Filings Classification · 90% confidence The document is titled '江西昌九生物化工股份有限公司未来三年股东回报规划（2020-2022年）' which translates to 'Jiangxi Changjiu Bio-chemical Co., Ltd. Future Three-Year Shareholder Return Plan (2020-2022)'. It outlines the company's dividend policy, conditions for cash dividends, stock dividends, and the decision-making process for shareholder returns over the next three years. The document is a policy or plan related to dividends and shareholder returns, not an announcement of dividend amounts or payment dates. It is also not a formal dividend notice, but rather a strategic plan for shareholder returns. Given the content and length (1926 characters), it is not a full financial report or earnings release. It is a detailed plan related to dividends and shareholder returns, which fits best under the category of Notice of Dividend Amount (DIV) as it relates to dividend policy and shareholder returns planning. However, since it is a plan for future dividends rather than an announcement of specific dividend amounts or payment dates, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory disclosure about dividend policy and shareholder return planning, not a formal dividend notice or report. Therefore, the best classification is Regulatory Filings (RNS).
2020-09-17 Chinese
独立董事关于公司董事会第十八次会议相关议案的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the pre-approval of proposals related to a major asset restructuring, share issuance, and related party transactions to be discussed at the company's 7th Board of Directors 18th meeting. It references compliance with various laws and regulations, including the Company Law, Securities Law, and rules on major asset restructuring. The document is not a full report but an official statement or opinion on agenda items for a board meeting, specifically related to a major transaction and associated governance procedures. It does not contain financial statements or detailed financial data but rather a governance and compliance opinion on proposed board resolutions. This fits best under Board/Management Information (MANG), which covers announcements of board-related decisions and management information, especially regarding governance and transaction approvals.
2020-09-17 Chinese
独立董事关于公司董事会第十八次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on proposals related to a major asset restructuring, share issuance, and related party transactions. It references compliance with company law, securities law, and regulatory rules, and discusses the fairness and legality of the transaction. The document is a formal opinion letter from independent directors rather than a full report or announcement of voting results. It does not contain financial statements or earnings data, nor is it a simple announcement or certification. The content focuses on governance and approval of board meeting proposals related to a major transaction. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board decisions and management-related information.
2020-09-17 Chinese
华泰联合证券有限责任公司关于江西昌九生物化工股份有限公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易之独立财务顾问专业意见附表第3号——发行股份购买资产
Capital/Financing Update Classification · 95% confidence The document is a detailed independent financial advisor's professional opinion report related to a major asset swap, issuance of shares, cash payment for asset purchase, and fundraising by Jiangxi Changjiu Bio-chemical Co., Ltd. It includes extensive due diligence, compliance checks, transaction pricing fairness, and impact analysis on the company. The content is consistent with a financial advisory report for a significant corporate transaction involving issuance of shares and asset acquisition, typical of a Capital/Financing Update. It is not a full annual or interim report, audit report, or earnings release. It is not a simple announcement or certification but a substantive advisory opinion document. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (11785 characters) and detailed content support this classification with high confidence.
2020-09-17 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.